These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 21705677)

  • 21. Sphingosine 1-phosphate and isoform-specific activation of phosphoinositide 3-kinase beta. Evidence for divergence and convergence of receptor-regulated endothelial nitric-oxide synthase signaling pathways.
    Igarashi J; Michel T
    J Biol Chem; 2001 Sep; 276(39):36281-8. PubMed ID: 11470796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FTY720 attenuates hypoxia-reoxygenation-induced apoptosis in cardiomyocytes.
    Wang M; Lu L; Liu Y; Gu G; Tao R
    Exp Mol Pathol; 2014 Oct; 97(2):218-24. PubMed ID: 25034934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling.
    Das A; Xi L; Kukreja RC
    J Biol Chem; 2005 Apr; 280(13):12944-55. PubMed ID: 15668244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoting effect of baicalin on nitric oxide production in CMECs via activating the PI3K-AKT-eNOS pathway attenuates myocardial ischemia-reperfusion injury.
    Bai J; Wang Q; Qi J; Yu H; Wang C; Wang X; Ren Y; Yang F
    Phytomedicine; 2019 Oct; 63():153035. PubMed ID: 31377586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate.
    Tao R; Hoover HE; Honbo N; Kalinowski M; Alano CC; Karliner JS; Raffai R
    Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H1022-8. PubMed ID: 20061542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FTY720 attenuates hepatic ischemia-reperfusion injury in normal and cirrhotic livers.
    Man K; Ng KT; Lee TK; Lo CM; Sun CK; Li XL; Zhao Y; Ho JW; Fan ST
    Am J Transplant; 2005 Jan; 5(1):40-9. PubMed ID: 15636610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. cGMP-Elevating Compounds and Ischemic Conditioning Provide Cardioprotection Against Ischemia and Reperfusion Injury via Cardiomyocyte-Specific BK Channels.
    Frankenreiter S; Bednarczyk P; Kniess A; Bork NI; Straubinger J; Koprowski P; Wrzosek A; Mohr E; Logan A; Murphy MP; Gawaz M; Krieg T; Szewczyk A; Nikolaev VO; Ruth P; Lukowski R
    Circulation; 2017 Dec; 136(24):2337-2355. PubMed ID: 29051185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sphingosine kinase and sphingosine 1-phosphate in cardioprotection.
    Karliner JS
    J Cardiovasc Pharmacol; 2009 Mar; 53(3):189-97. PubMed ID: 19247197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase. differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells.
    Igarashi J; Bernier SG; Michel T
    J Biol Chem; 2001 Apr; 276(15):12420-6. PubMed ID: 11278407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways.
    Chen Y; Ba L; Huang W; Liu Y; Pan H; Mingyao E; Shi P; Wang Y; Li S; Qi H; Sun H; Cao Y
    Eur J Pharmacol; 2017 Feb; 796():90-100. PubMed ID: 27916558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning.
    Vessey DA; Li L; Honbo N; Karliner JS
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1429-35. PubMed ID: 19648253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sphingosine 1-phosphate promotes mesenchymal stem cell-mediated cardioprotection against myocardial infarction via ERK1/2-MMP-9 and Akt signaling axis.
    Chen R; Cai X; Liu J; Bai B; Li X
    Life Sci; 2018 Dec; 215():31-42. PubMed ID: 30367841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sphingosine can pre- and post-condition heart and utilizes a different mechanism from sphingosine 1-phosphate.
    Vessey DA; Li L; Kelley M; Zhang J; Karliner JS
    J Biochem Mol Toxicol; 2008; 22(2):113-8. PubMed ID: 18418901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR is involved in sphingosine 1-phosphate-stimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS).
    Tanimoto T; Jin ZG; Berk BC
    J Biol Chem; 2002 Nov; 277(45):42997-3001. PubMed ID: 12226078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sphingosine-1-phosphate receptor 2 mediates endothelial cells dysfunction by PI3K-Akt pathway under high glucose condition.
    Liu W; Liu B; Liu S; Zhang J; Lin S
    Eur J Pharmacol; 2016 Apr; 776():19-25. PubMed ID: 26921757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Salvia miltiorrhiza and ligustrazine injection on myocardial ischemia/reperfusion and hypoxia/reoxygenation injury.
    Huang W; Yang Y; Zeng Z; Su M; Gao Q; Zhu B
    Mol Med Rep; 2016 Nov; 14(5):4537-4544. PubMed ID: 27748867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection.
    Somers SJ; Frias M; Lacerda L; Opie LH; Lecour S
    Cardiovasc Drugs Ther; 2012 Jun; 26(3):227-37. PubMed ID: 22392184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The study on protective effect of sphingosine-1-phosphate in cardiomyocytes].
    Yuan L; Zhang WJ; Zhang DD; Zhao CY
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2011 Aug; 27(3):320-3. PubMed ID: 22097726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional characterization of sphingosine 1-phosphate receptor agonist in human endothelial cells.
    Butler J; Lana D; Round O; LaMontagne K
    Prostaglandins Other Lipid Mediat; 2004 Jan; 73(1-2):29-45. PubMed ID: 15165029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low dose N, N-dimethylsphingosine is cardioprotective and activates cytosolic sphingosine kinase by a PKCepsilon dependent mechanism.
    Jin ZQ; Karliner JS
    Cardiovasc Res; 2006 Sep; 71(4):725-34. PubMed ID: 16831409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.